💨 Abstract

Atara Biotherapeutics Inc. (ATRA) reported first-quarter net income of $38 million, reversing a loss from the previous year. The company earned $3.50 per share and recorded $98.1 million in revenue. However, its stock has significantly declined, down 50% since the beginning of 2025 and 56% over the past year.

Courtesy: wtop.com